New breathing device could keep kids safer during surgery

NCT ID NCT06425406

Recruiting now Prevention Sponsor: Henan Provincial People's Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a high-flow nasal cannula (HFNC) can prevent dangerously low oxygen levels in children aged 2-10 during anesthesia before intubation. Researchers will compare safe apnea time—how long oxygen stays above 95%—in 48 healthy children. If effective, HFNC could become a standard tool to reduce complications like lung collapse.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: high-flow nasal cannula (HFNC) device
What this could lead to: If successful, this could establish a safer way to keep oxygen levels stable during anesthesia in children, reducing risks of low oxygen and lung collapse.
What could go wrong: This is a small, early-stage trial with only 48 children, so results may not apply to all kids. The device may not prevent low oxygen in every case.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILDREN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHILDREN HIGH FLOW NASAL CANNULA PRE-OXYGENATION

Contacts and locations

Locations

Department of Anaesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital
RECRUITING

Zhengzhou, Henan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.